PT Kalbe Farma Tbk. (PTKFY)
OTCMKTS · Delayed Price · Currency is USD
13.57
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
PT Kalbe Farma Tbk. Market Cap
PT Kalbe Farma Tbk. has a market cap or net worth of $2.98 billion as of February 12, 2026. Its market cap has decreased by -19.18% in one year.
Market Cap
2.98B
Enterprise Value
2.87B
Revenue
2.06B
Ranking
n/a
PE Ratio
14.25
Stock Price
$13.57
Market Cap Chart
Since February 26, 1992, PT Kalbe Farma Tbk.'s market cap has increased from 96.30M to 2.98B, an increase of 2,997.62%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.97B | -8.79% |
| Dec 30, 2025 | 3.26B | -16.31% |
| Dec 30, 2024 | 3.89B | -19.49% |
| Dec 29, 2023 | 4.83B | -22.39% |
| Dec 30, 2022 | 6.23B | 17.30% |
| Dec 30, 2021 | 5.31B | 7.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Glass House Brands | 710.47M |
| Elite Pharmaceuticals | 464.34M |
| Northwest Biotherapeutics | 411.40M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| OpGen | 340.99M |
| CytoDyn | 311.51M |